Profil
Nkechi Azie worked as the Director of Anti-infective Clinical Development at Pfizer Inc. from 1998 to 2006.
She then served as the Senior Director of Medical Affairs at Astellas Pharma US, Inc. from 2006 to 2016.
After that, she held the position of Senior Vice President of Medical Affairs at The Medicines Co. Currently, she is the VP of Clinical Development & Medical Affairs at SCYNEXIS, Inc. Dr. Azie completed her undergraduate studies at the University of Nigeria and obtained an MBA from the Mendoza College of Business.
Ehemalige bekannte Positionen von Nkechi Azie
| Unternehmen | Position | Ende |
|---|---|---|
| SCYNEXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.09.2023 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2006 |
| THE MEDICINES COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Nkechi Azie
| Mendoza College of Business | Masters Business Admin |
| University of Nigeria | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SCYNEXIS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
